These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17195469)

  • 1. Systems biology and its impact on anti-infective drug development.
    Stumpf MP; Robertson BD; Duncan K; Young DB
    Prog Drug Res; 2007; 64():1, 3-20. PubMed ID: 17195469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of synthetic biology on drug discovery.
    Weber W; Fussenegger M
    Drug Discov Today; 2009 Oct; 14(19-20):956-63. PubMed ID: 19580884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico systems biology approaches for the identification of antimicrobial targets.
    Sarker M; Talcott C; Galande AK
    Methods Mol Biol; 2013; 993():13-30. PubMed ID: 23568461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug target identification through systems biology.
    Haanstra JR; Bakker BM
    Drug Discov Today Technol; 2015 Aug; 15():17-22. PubMed ID: 26464086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the mode-of-action of compounds from metabolite profiling studies.
    Højer-Pedersen J; Smedsgaard J; Nielsen J
    Prog Drug Res; 2007; 64():103, 105-29. PubMed ID: 17195473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems Biology: A Powerful Tool for Drug Development.
    Rai S; Raj U; Varadwaj PK
    Curr Top Med Chem; 2018; 18(20):1745-1754. PubMed ID: 30360720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving a Predictive Understanding of Antimicrobial Stress Physiology through Systems Biology.
    Mack SG; Turner RL; Dwyer DJ
    Trends Microbiol; 2018 Apr; 26(4):296-312. PubMed ID: 29530606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.
    Wathieu H; Issa NT; Byers SW; Dakshanamurthy S
    Curr Pharm Des; 2016; 22(21):3097-108. PubMed ID: 26907947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-infectious drug repurposing using an integrated chemical genomics and structural systems biology approach.
    Ng C; Hauptman R; Zhang Y; Bourne PE; Xie L
    Pac Symp Biocomput; 2014; ():136-47. PubMed ID: 24297541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery.
    Bosl WJ
    BMC Syst Biol; 2007 Feb; 1():13. PubMed ID: 17408503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
    Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Brunak S; Butte A; Califano A; Celis J; Cufer T; Ferrell J; Galas D; Gallahan D; Gatenby R; Goldbeter A; Hace N; Henney A; Hood L; Iyengar R; Jackson V; Kallioniemi O; Klingmüller U; Kolar P; Kolch W; Kyriakopoulou C; Laplace F; Lehrach H; Marcus F; Matrisian L; Nolan G; Pelkmans L; Potti A; Sander C; Seljak M; Singer D; Sorger P; Stunnenberg H; Superti-Furga G; Uhlen M; Vidal M; Weinstein J; Wigle D; Williams M; Wolkenhauer O; Zhivotovsky B; Zinovyev A; Zupan B
    Mol Oncol; 2009 Feb; 3(1):9-17. PubMed ID: 19383362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging paradigms in anti-infective drug design.
    Barrett MP; Croft SL
    Parasitology; 2014 Jan; 141(1):1-7. PubMed ID: 24401336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of genomics on discovering drugs against infectious diseases.
    Boshoff HI; Manjunatha UH
    Microbes Infect; 2006 May; 8(6):1654-61. PubMed ID: 16690340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
    Rayner CR; Smith PF; Andes D; Andrews K; Derendorf H; Friberg LE; Hanna D; Lepak A; Mills E; Polasek TM; Roberts JA; Schuck V; Shelton MJ; Wesche D; Rowland-Yeo K
    Clin Pharmacol Ther; 2021 Apr; 109(4):867-891. PubMed ID: 33555032
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.